化学抗原受体-自然杀手细胞疗法:当前的进展和克服挑战的策略
Jun Chang Kong1, Mohammad Auwal Sa'ad2,3, Hema Manusri Vijayan2
1Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Minden, Penang, Malaysia.
Frontiers in immunology
|May 10, 2024
概括
化学抗原受体自然杀手 (CAR-NK) 细胞疗法提供了强大的癌细胞向,副作用较少. 本综述探讨了CAR-NK的进展,局限性和克服瘤微环境挑战的策略.
科学领域:
- 免疫治疗是一种免疫疗法.
- 细胞疗法细胞疗法
- 在瘤学瘤学.
背景情况:
- 化学抗原受体自然杀手 (CAR-NK) 细胞疗法是一种新兴的免疫疗法.
- 卡尔-NK细胞向癌症抗原,具有强大的细胞毒性,可减少CRS,神经毒性和GvHD等副作用.
- 由于不需要抗原原始化,CAR-NK细胞可以用作"现成"疗法.
研究的目的:
- 审查CAR-NK细胞疗法的当前进展和局限性.
- 讨论克服瘤微环境带来的挑战的策略.
- 分析临床试验状况,并提供改善CAR-NK疗法的有效性和安全性的建议.
主要方法:
- 关于CAR-NK细胞治疗进展的文献综述.
- 分析缺氧和免疫抑制瘤微环境中的挑战.
- 检查临床试验数据和未来研究方向.
主要成果:
- 卡尔-NK疗法对向癌症治疗有望,具有有利的安全性.
- 在克服免疫抑制瘤微环境方面仍然存在挑战.
- 目前正在进行的临床试验正在评估CAR-NK细胞治疗的疗效和安全性.
结论:
- CAR-NK细胞疗法是一种有前途的免疫疗法,具有显著的潜力.
- 需要采取战略来提高瘤微环境中的CAR-NK疗效.
- 进一步的临床评估对于优化癌症治疗的CAR-NK疗法至关重要.
相关概念视频
01:27Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518
01:27Cytotoxic T Cells-mediated Immune Response
901
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
901